3.610USD-1.09%Mkt Cap: 39.63M USDP/E: 52.14Last update: 2026-06-01
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers …
Industry Peers
Medical Instruments & SuppliesIndicators:|
Key Statistics
Company
Market Cap39.63M USD
Enterprise Value36.68M USD
Revenue (TTM)19.12M USD
Gross Profit11.63M USD
Net Income (TTM)1.19M USD
Revenue/Share1.800 USD
Last Price3.610 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees36
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)52.14
P/E (Forward)36.60
PEG—
EV/EBITDA45.69
EV/Revenue1.92
P/S2.08
P/B3.71
EPS (TTM)0.07
EPS (Forward)0.10
52W Range
2.56027% of range6.420
52W High6.420 USD
52W Low2.560 USD
Profitability
Gross Margin61.87%
Oper. Margin1.86%
EBITDA Margin4.20%
Profit Margin6.35%
ROE11.70%
ROA8.75%
Growth
Revenue Growth6.90%
Earnings Growth-80.00%
Cash Flow & Leverage
Operating CF1.65M USD
CapEx (TTM)—
FCF Margin-4.04%
FCF Yield-1.95%
Net Debt-3.05M USD
Net Debt/EBITDA-3.80
Balance Sheet
Debt/Equity0.10
Current Ratio4.55
Quick Ratio2.98
Book Value/Sh0.9870 USD
Cash/Share0.3700 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 10, 2019
Splits
Last Split1:9
Split DateJul 10, 2019
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)7.000 USD
Target Range6.000 USD – 8.000 USD
# Analysts2
Ownership
Shares Out.10.86M
Float8.83M
Insiders12.84%
Institutions49.48%
Short Interest
Short Ratio0.7d
Short % Float0.32%
Short % Out.0.20%
Shares Short21.19K
Short (prev mo.)41.49K
Technical
SMA 503.128 (+15.4%)
SMA 2004.218 (-14.4%)
Beta1.47
S&P 52W Chg27.94%
Avg Vol (30d)30.48K
Avg Vol (10d)32.44K
Technical Indicators
RSI (14)57.2
MACD0.1321
MACD Signal0.1090
MACD Hist.+0.0231
BB Upper3.892 USD
BB Middle3.386 USD
BB Lower2.881 USD
BB Width29.83%
ATR (14)0.2663 USD
Vol Ratio (20d)0.12x